To identify genes and signaling pathways that are modulated by MAGI1 loss in ER+ BC cells, we decided to inactivate the MAGI1 gene in ER+HER2− MCF7 cells using the CRISPR/Cas9 strategy. The gene discussed is ERBB2; the disease is breast cancer.